MedTrace Logo

The Immune Response to Stroke

NCT05277129 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-03-14

No results posted yet for this study

Summary

Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.

Conditions

Interventions

OTHER

Analysis of post-stroke immune responses

Analysis of immune responses in peripheral blood

Sponsors & Collaborators

  • University of Oslo

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-24
Primary Completion
2025-12-31
Completion
2029-06-06

Countries

  • Norway

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05277129 on ClinicalTrials.gov